Scholarlink

Purpose <p>Differentiating radiation necrosis (RN) from tumor recurrence (TR) in previously irradiated brain metastases (BM) remains a challenge. Imaging techniques lack sufficient diagnostic reliability, while therapeutic implications differ between both entities. This study aims to evaluate the diagnostic, therapeutic, and prognostic value of surgery in patients with progressive irradiated BM.</p> Methods <p>We studied patients who underwent surgical resection for progressive BM after prior irradiation. Histopathological diagnosis was classified as pure RN or TR. Clinical, radiological, surgical, and survival outcomes were analyzed.</p> Results <p>In 73 lesions, histopathology demonstrated TR in 68.5% of lesions. Among TR, 84.0% showed mixed pathological features combining viable tumor cells and radionecrotic patterns. Patients initially treated by irradiation alone were significantly more likely to present TR, whereas surgery followed by postoperative irradiation was significantly associated with RN. Median interval between radiation and surgery was significantly longer in the RN group and breast cancer seemed related to RN. Postoperative clinical improvement occurred in 80.4% of symptomatic patients and corticosteroid discontinuation within one month occurred in 72.3% of patients, without significant difference between RN and TR. Median overall survival was longer in patients with RN (39 vs. 19 months, <i>p</i> = 0.025).</p> Conclusion <p>Surgery provides diagnostic, therapeutic, and prognostic value in patients with progressive irradiated BM. Beyond diagnostic clarification, surgery provides significant symptomatic improvement and corticosteroid withdrawal regardless of final pathology. Histopathological diagnosis influences survival outcomes and subsequent oncological management.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The threefold value of surgery in previously irradiated brain metastases

  • 期刊论文

  • 发表日期：

    2026年7月22日

查看全文
  • Joshua Marchal,
  • Lucas Ybert,
  • Mathilde Ducloie,
  • Julien Geffrelot,
  • Maxime Faisant,
  • Grégoire Braux,
  • Paul Lesueur,
  • Nicolas Goliot,
  • Victor Pernin,
  • Thomas Gaberel,
  • Evelyne Emery,
  • Arthur Leclerc

摘要

Purpose

Differentiating radiation necrosis (RN) from tumor recurrence (TR) in previously irradiated brain metastases (BM) remains a challenge. Imaging techniques lack sufficient diagnostic reliability, while therapeutic implications differ between both entities. This study aims to evaluate the diagnostic, therapeutic, and prognostic value of surgery in patients with progressive irradiated BM.

Methods

We studied patients who underwent surgical resection for progressive BM after prior irradiation. Histopathological diagnosis was classified as pure RN or TR. Clinical, radiological, surgical, and survival outcomes were analyzed.

Results

In 73 lesions, histopathology demonstrated TR in 68.5% of lesions. Among TR, 84.0% showed mixed pathological features combining viable tumor cells and radionecrotic patterns. Patients initially treated by irradiation alone were significantly more likely to present TR, whereas surgery followed by postoperative irradiation was significantly associated with RN. Median interval between radiation and surgery was significantly longer in the RN group and breast cancer seemed related to RN. Postoperative clinical improvement occurred in 80.4% of symptomatic patients and corticosteroid discontinuation within one month occurred in 72.3% of patients, without significant difference between RN and TR. Median overall survival was longer in patients with RN (39 vs. 19 months, p = 0.025).

Conclusion

Surgery provides diagnostic, therapeutic, and prognostic value in patients with progressive irradiated BM. Beyond diagnostic clarification, surgery provides significant symptomatic improvement and corticosteroid withdrawal regardless of final pathology. Histopathological diagnosis influences survival outcomes and subsequent oncological management.

Graphical Abstract